Abstract
Background
Hepatitis B virus (HBV) has a crucial role in the progression of hepatocellular carcinoma (HCC). Tumour cells must develop anoikis resistance in order to survive before metastasis. This study aimed to investigate the mechanism of IQGAP1 in HBV-mediated anoikis evasion and metastasis in HCC cells.
Methods
IQGAP1 expression was detected by immunohistochemistry, real-time PCR and immunoblot analysis. Lentiviral-mediated stable upregulation or knockdown of IGAQP1, immunoprecipitation, etc. were used in function and mechanism study.
Results
IQGAP1 was markedly upregulated in HBV-positive compared with HBV-negative HCC cells and tissues. IQGAP1 was positively correlated to poor prognosis of HBV-associated HCC patients. IQGAP1 overexpression significantly enhanced the anchorage-independent growth and metastasis, whereas IQGAP1-deficient HCC cells are more sensitive to anoikis. Mechanistically, we found that HBV-induced ROS enhanced the association of IQGAP1 and Rac1 that activated Rac1, leading to phosphorylation of Src/FAK pathway. Antioxidants efficiently inhibited IQGAP1-mediated anoikis resistance and metastasis.
Conclusions
Our study indicated an important mechanism by which upregulated IQGAP1 by HBV promoted anoikis resistance, migration and invasion of HCC cells through Rac1-dependent ROS accumulation and activation of Src/FAK signalling, suggesting IQGAP1 as a prognostic indicator and a novel therapeutic target in HCC patients with HBV infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
06 April 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01355-4
10 June 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01449-z
References
Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J. Clin. 64, 9–29 (2014).
Joung, Y. H., Park, S. H., Moon, K. B., Jeon, J. H., Cho, H. S. & Kim, H. S. The last ten years of advancements in plant-derived recombinant vaccines against hepatitis B. Int. J. Mol. Sci. 17, 1715 (2016).
Yuan, P., Chen, P. & Qian, Y. Evaluation of antiviral therapy performed after curative therapy in patients with HBV-related hepatocellular carcinoma: an updated meta-analysis. Can. J. Gastroenterol. Hepatol. 2016, 5234969 (2016).
Jia, Q., Dong, Q. & Qin, L. CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma? Oncotarget 7, 1203–1214 (2016).
Collins, N. L., Reginato, M. J., Paulus, J. K., Sgroi, D. C., Labaer, J. & Brugge, J. S. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol. Cell. Biol. 25, 5282–5291 (2005).
Horowitz, J. C., Rogers, D. S., Sharma, V., Vittal, R., White, E. S., Cui, Z. et al. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal. 19, 761–771 (2007).
Fofaria, N. M. & Srivastava, S. K. Critical role of STAT3 in melanoma metastasis through anoikis resistance. Oncotarget 5, 7051–7064 (2014).
Xu, J., Liu, H., Chen, L., Wang, S., Zhou, L., Yun, X. et al. Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology 143, 199–212 (2012).
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M. et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl Acad. Sci. USA 107, 8788–8793 (2010).
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y. et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461, 109–113 (2009).
Ren, J. H., Chen, X., Zhou, L., Tao, N. N., Zhou, H. Z., Liu, B. et al. Protective role of Sirtuin3 (SIRT3) in oxidative stress mediated by hepatitis B virus X protein expression. PloS ONE 11, e0150961 (2016).
Schinzari, V., Barnaba, V. & Piconese, S. Chronic hepatitis B virus and hepatitis C virus infections and cancer: synergy between viral and host factors. Clin. Microbiol. Infect. 21, 969–974 (2015).
Lim, W., Kwon, S. H., Cho, H., Kim, S., Lee, S., Ryu, W. S. et al. HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression. J. Mol. Med. 88, 359–369 (2010).
Cho, M. Y., Cheong, J. Y., Lim, W., Jo, S., Lee, Y., Wang, H. J. et al. Prognostic significance of catalase expression and its regulatory effects on hepatitis B virus X protein (HBx) in HBV-related advanced hepatocellular carcinomas. Oncotarget 5, 12233–12246 (2014).
Briggs, M. W. & Sacks, D. B. IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep. 4, 571–574 (2003).
Johnson, M., Sharma, M. & Henderson, B. R. IQGAP1 regulation and roles in cancer. Cell Signal. 21, 1471–1478 (2009).
White, C. D., Brown, M. D. & Sacks, D. B. IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett. 583, 1817–1824 (2009).
David, S., Ghosh, C. C., Mukherjee, A. & Parikh, S. M. Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense. Arterioscler. Thromb. Vasc. Biol. 31, 2643–2652 (2011).
Brown, M. D., Bry, L., Li, Z. & Sacks, D. B. IQGAP1 regulates Salmonella invasion through interactions with actin, Rac1, and Cdc42. J. Biol. Chem. 282, 30265–30272 (2007).
Dong, P., Nabeshima, K., Nishimura, N., Kawakami, T., Hachisuga, T., Kawarabayashi, T. et al. Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas. Cancer Lett. 243, 120–127 (2006).
Nabeshima, K., Shimao, Y., Inoue, T. & Koono, M. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. Cancer Lett. 176, 101–109 (2002).
Lupberger, J., Mund, A., Kock, J. & Hildt, E. Cultivation of HepG2.2.15 on Cytodex-3: higher yield of hepatitis B virus and less subviral particles compared to conventional culture methods. J. Hepatol. 45, 547–552 (2006).
Ladner, S. K., Otto, M. J., Barker, C. S., Zaifert, K., Wang, G. H., Guo, J. T. et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41, 1715–1720 (1997).
Yuan, K., Lei, Y., Chen, H. N., Chen, Y., Zhang, T., Li, K. et al. HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3. Cell Death Differ. 23, 616–627 (2016).
Li, K., Mo, C., Gong, D., Chen, Y., Huang, Z., Li, Y. et al. DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of beta-catenin. Cancer lett. 400, 194–202 (2017).
Mo, C., Wang, L., Zhang, J., Numazawa, S., Tang, H., Tang, X. et al. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid. Redox Signal. 20, 574–588 (2014).
Zhao, X., Fu, J., Xu, A., Yu, L., Zhu, J., Dai, R. et al. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death Dis. 6, e1751 (2015).
Pedanou, V. E., Gobeil, S., Tabaries, S., Simone, T. M., Zhu, L. J., Siegel, P. M. et al. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L. elife 5, e16844 (2016).
Li, K., Zhao, G., Ao, J., Gong, D., Zhang, J., Chen, Y. et al. ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma. Cancer lett. 442, 271–278 (2019).
Sood, A. K., Armaiz-Pena, G. N., Halder, J., Nick, A. M., Stone, R. L., Hu, W. et al. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J. Clin. Invest. 120, 1515–1523 (2010).
Park, E. K., Park, M. J., Lee, S. H., Li, Y. C., Kim, J., Lee, J. S. et al. Cholesterol depletion induces anoikis-like apoptosis via FAK down-regulation and caveolae internalization. J. Pathol. 218, 337–349 (2009).
Panera, N., Crudele, A., Romito, I., Gnani, D. & Alisi, A. Focal adhesion kinase: insight into molecular roles and functions in hepatocellular carcinoma. Int. J. Mol. Sci. 18, 99 (2017).
Kim, S., Kim, H. Y., Lee, S., Kim, S. W., Sohn, S., Kim, K. et al. Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and Dynein-dependent manners. J. Virol. 81, 1714–1726 (2007).
Azam, F. & Koulaouzidis, A. Hepatitis B virus and hepatocarcinogenesis. Ann. Hepatol. 7, 125–129 (2008).
Dolnik, O., Kolesnikova, L., Welsch, S., Strecker, T., Schudt, G. & Becker, S. Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells. PLoS Pathog. 10, e1004463 (2014).
Morita, E., Sandrin, V., Chung, H. Y., Morham, S. G., Gygi, S. P., Rodesch, C. K. et al. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 26, 4215–4227 (2007).
Lu, J., Qu, Y., Liu, Y., Jambusaria, R., Han, Z., Ruthel, G. et al. Host IQGAP1 and Ebola virus VP40 interactions facilitate virus-like particle egress. J. Virol. 87, 7777–7780 (2013).
Wang, Z., Li, Z., Ye, Y., Xie, L. & Li, W. Oxidative stress and liver cancer: etiology and therapeutic targets. Oxid. Med. Cell. Longev. 2016, 7891574 (2016).
Wang, R., Yin, C., Li, X. X., Yang, X. Z., Yang, Y., Zhang, M. Y. et al. Reduced SOD2 expression is associated with mortality of hepatocellular carcinoma patients in a mutant p53-dependent manner. Aging 8, 1184–1200 (2016).
Diekmann, D., Abo, A., Johnston, C., Segal, A. W. & Hall, A. Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 265, 531–533 (1994).
Bromberg, Y., Shani, E., Joseph, G., Gorzalczany, Y., Sperling, O. & Pick, E. The GDP-bound form of the small G protein Rac1 p21 is a potent activator of the superoxide-forming NADPH oxidase of macrophages. J. Biol. Chem. 269, 7055–7058 (1994).
Sulzmaier, F. J., Jean, C. & Schlaepfer, D. D. FAK in cancer: mechanistic findings and clinical applications. Nat. Rev. Cancer 14, 598–610 (2014).
Lee, B. Y., Timpson, P., Horvath, L. G. & Daly, R. J. FAK signaling in human cancer as a target for therapeutics. Pharmacol. Ther. 146, 132–149 (2015).
Subramani, J., Ghosh, M., Rahman, M. M., Caromile, L. A., Gerber, C., Rezaul, K. et al. Tyrosine phosphorylation of CD13 regulates inflammatory cell-cell adhesion and monocyte trafficking. J. Immunol. 191, 3905–3912 (2013).
Giannoni, E., Fiaschi, T., Ramponi, G. & Chiarugi, P. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 28, 2074–2086 (2009).
Chiarugi, P., Pani, G., Giannoni, E., Taddei, L., Colavitti, R., Raugei, G. et al. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 161, 933–944 (2003).
Ribeiro-Pereira, C., Moraes, J. A., Souza Mde, J., Laurindo, F. R., Arruda, M. A. & Barja-Fidalgo, C. Redox modulation of FAK controls melanoma survival-role of NOX4. PloS ONE 9, e99481 (2014).
Author information
Authors and Affiliations
Contributions
C.F.M., J.L. and S.X.Y. designed the project and performed all the experiments. H.J.G. and X.Y.L. helped to conduct animal experiments. J.L. and Y.T.W. provided clinical samples. C.F.M. wrote the manuscript. C.F.M., S.X.Y., Y.L. and M.H.L. interpreted data and revised the manuscript. J.Y.L. and Q.Z. supervised the research.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Tumour tissues samples were collected from HCC patients who underwent surgical resection at the First Affiliated Hospital of Chengdu Medical College (Chengdu, China). The patients agreed to enter the study and signed the informed consent. This study was approved by the Committee for Ethical Review of Research involving Human Subjects of the First Affiliated Hospital of Chengdu Medical College and was performed in accordance with the Declaration of Helsinki. The clinical pathological information of HCC patients was summarised in Table 1. All animal experiments were performed in accordance with relevant guidelines and regulations and approved by the Institutional Animal Care and Use Committee of Chengdu Medical College.
Consent to publish
Not applicable.
Data availability
The datasets generated and/or analysed during the current study are not publicly available but are available from the corresponding author on reasonable request.
Competing interests
The authors declare no competing interests.
Funding information
This study was supported by the National Natural Science Foundation of China (81402944, 81702446, 81871300), Application and Basic Project of Science and Technology Department of Sichuan Province (2018JY0440, 2017JY0174) and Research Fund of Chengdu Medical College (CYZ16-01).
Additional information
Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: There was an error in the funding information.
Supplementary information
Rights and permissions
About this article
Cite this article
Mo, Cf., Li, J., Yang, Sx. et al. IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src/FAK signalling in hepatocellular carcinoma. Br J Cancer 123, 1154–1163 (2020). https://doi.org/10.1038/s41416-020-0970-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-020-0970-z
This article is cited by
-
Anoikis related genes may be novel markers associated with prognosis for ovarian cancer
Scientific Reports (2024)
-
Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells
Journal of Translational Medicine (2023)
-
Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment
Cell Communication and Signaling (2023)
-
Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma
Journal of Cancer Research and Clinical Oncology (2023)
-
A Novel Signature Based on Anoikis Associated with BCR-Free Survival for Prostate Cancer
Biochemical Genetics (2023)